NK

Naresh Kumar Ganji

Active Director Director DIN 07510909
DIN 07510909 First appointment Aug 2016 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value •••• Premium profile

About Naresh Kumar Ganji

Data last updated:

Naresh Kumar Ganji is a Director at Ryon Pharma And Infra Private Limited (since 2016). The company operates in Professional Services. Ryon Pharma And Infra Private Limited reported revenue of ₹20.5 Lakh (FY 2019).

DIN 07510909
Primary Designation Director
Industry Professional Services
First Appointment 11 Aug 2016
Oldest Company Age 10 yrs
Largest company Ryon Pharma And Infra Private Limited · ₹20.5 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Aug 20162016₹20.5 Lakh (FY 2019)Active

Board colleagues of Naresh Kumar Ganji

NameDINCompanyDesignation
Kartheek Ganji07483857Ryon Pharma And Infra Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ryon Pharma And Infra Private Limited
Premium access

Shareholding and investment profile for Naresh Kumar Ganji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Kumar Ganji

Naresh Kumar Ganji currently holds 1 directorship: Ryon Pharma And Infra Private Limited (Director, since 11 Aug 2016, revenue ₹20.5 Lakh (FY 2019)).

Naresh Kumar Ganji was first appointed on 11 Aug 2016 as Director at Ryon Pharma And Infra Private Limited.

The current boards of Naresh Kumar Ganji's companies include Kartheek Ganji (Ryon Pharma And Infra Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available